 |
|
|
| |
Survival Benefit of Direct-Acting Antiviral Therapy in Patients with Decompensated Cirrhosis
|
| |
| |
Reported by Jules Levin
AASLD Annual Meeting 2017, Washington, DC, USA, October 20-24
W. Ray Kim1, Ajitha Mannalithara1, Haewon Lee1, Anu O. Osinusi2, Raul E. Aguilar Schall2, Diana M. Brainard2
1Division of Gastroenterology and Hepatology , Stanford University, Stanford, CA; 2Gilead Sciences, Inc., Foster City, CA
|
| |
|
|
|
|
|
